Hold TXN at $235 entry; four staged add triggers and three trim triggers with Q3 earnings as binary catalyst
Hold TXN at $235 entry, which is structurally excellent (rising 200 SMA at $235.96, 8% above trend line, Dividend Aristocrat, 35% ROE, fortress balance sheet, $7B cash, FCF inflection from $555M to $2.19B YoY). No adds or trims at $254. The aggressive case (FCF inflection, 23% correction, ATR compression, lower Bollinger positioning) is undermined by the 8/7 Overweight precedent at $288 (-1.9% alpha) and MACD re-widening to -1.06. The conservative case (broken chart, 29% receivables growth outpacing revenue, $4.6B elevated inventory, 23.9x forward P/E) is undermined by the 8/27 Underweight lesson (-2.7% alpha) and QCOM 9/1 lesson on cyclical compression resolution. Three refinements to trader's plan: (1) add Tier 1 partial trigger at confirmed lower Bollinger bounce, (2) soften Tier 3 breakout volume from 6M to 5M, (3) add relief-bounce trim trigger at $265-270. Let Q3 print resolve bull/bear standoff.
| Position | Action |
|---|---|
| Current $254 price level | Maintain current exposure; no adds or trims |
| Tier 1: Confirmed bounce off $250.16 lower Bollinger with bullish price action (hammer, engulfing, or 3 consecutive higher closes on rising volume) AND RSI <45 | Add 25% of intended increment |
| Tier 2: Price retests $235-242 zone with RSI divergence (sub-30 on retest, rising on recovery) AND declining MACD histogram magnitude | Add 25% of intended increment |
| Tier 3: Daily close above $282 on volume >5M AND MACD turning positive AND RSI >50 | Add 25% of intended increment |
| Tier 4: Q3 revenue >$5.5B sequential AND inventory drawdown AND buyback resumption announcement | Add final 25% of intended increment; upgrade to Overweight outright |
| Relief bounce into $265-270 zone (10 EMA level) | Trim 10-15% to capture alpha while preserving structural thesis exposure |
| Weekly close below $235 200 SMA | Trim 25-30%; move residual stop to $215-220 zone |
| Q3 revenue flat/down sequentially OR inventory builds OR conservative guide | Trim 20-25%; maintain residual for Q4 reversal; downgrade to Underweight if magnitude warrants |
TXN is a structurally mispriced asset experiencing a fundamental inflection driven by collapsing capex and exploding FCF, making the technical bearish case noise versus the underlying signal of record quarters, 60%+ EPS growth, and an untapped $10B+ annual FCF run-rate that will force aggressive buyback resumption.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 235.96 | bullish |
| close_50_sma | 282.19 | bearish |
| close_10_ema | 261.98 | bearish |
| rsi | 36.89 | neutral |
| macd | -7.23 | bearish |
| macds | -6.17 | bearish |
| macdh | -1.06 | bearish |
| boll_ub | 290.08 | neutral |
| boll_mid | 270.12 | neutral |
| boll_lb | 250.16 | neutral |
| atr | 9.16 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed bounce off $250.16 lower Bollinger band with bullish price action (hammer, engulfing, or 3 consecutive higher closes on rising volume) AND RSI still <45
Then: Add 25% of intended increment
The FCF explosion is just beginning because the $5B+ capex cycle is complete: quarterly capex collapsed 61% YoY from $1,305M to $514M, and annual FCF could reach $10B+ run-rate by year-end 2026.
↩ rebuts: “Bear ignores FCF dynamics entirely”
· concedes: RSI at 36.89 is weak and approaching oversold territory, confirming the stock has indeed declined from $330 to $255; MACD is deeply negative at -7.23 with histogram re-widening to -1.06; Trailing P/E of 38.7x is elevated on trough earnings; Social sentiment is only mildly bullish at 6.1/10
TXN's "FCF Tsunami" is a cyclical mirage at peak revenue—the Q2 FCF high-water mark is being extrapolated into a future that assumes cyclical perfection, when historical data shows 77% FCF drawdowns can occur in one year; combined with a 12.9x P/B, 38.7x TTM P/E, and technical momentum re-widening lower, the stock is a SELL into strength.
· concedes: Q2 2026 FCF of $2.19B and 61% capex decline are genuine data points; FCF data itself is real; P/B of 12.9x only works if ROE stays permanently at 35%; MACD was compressing in late August (about to form bullish crossover) before re-widening; Photomask demand firming is a real signal (but tangential and already in price)
→ vs conservative: 23.9 times forward P/E described as 'too optimistic' is misleading—the Q2 print shows 52% EPS growth YoY and 61% capex collapse, meaning the embedded earnings expansion is already happening, not forecasted
→ vs conservative: Trailing 38.7 times P/E is anchored to 2024 trough earnings when revenue collapsed 22% from peak; the correct frame is through-cycle normalized earnings on a 35.2% ROE business with fortress balance sheet
→ vs conservative: Pricing the stock as if buybacks never resume when 2022 buybacks were 3.6 billion versus TTM 700 million is the wrong base case—buyback resumption is a one-way catalyst
→ vs conservative: MACD histogram re-widening framing misses that waiting for confirmed bullish MACD cross means buying at 261 to 270 instead of 254.80 at the inflection
→ vs conservative: Conservative entry plan of 235-242 retest with RSI divergence only works if the stock does something that invalidates the very thesis justifying the entry—that is contingent buying in disguise
→ vs neutral: Waiting for confirmed close above 282 on 6 million volume means chasing after 15-20% rally with MACD already bullish and buyback announcement likely public—momentum buying, not asymmetric buying
→ vs neutral: Patience is a virtue when data is ambiguous; the data here is not ambiguous—it is telling us to act
→ vs conservative: Higher rates framing as headwind is wrong—89% odds of no Fed cuts in 2026 and 8% recession odds is a soft-landing backdrop where cash-generative cyclicals with industrial and auto exposure outperform
| vwma | 266.50 | bearish |
Support: 250.16 · 235.96 | Resistance: 261.98 · 270.12 · 282.19
TXN staged an explosive rally from ~$155-$160 in mid-November 2025 to a peak of $330.59 on 2026-06-22, gaining over 100% in roughly seven months before correcting ~23% to the current $254.80. Price sits ~9.7% below the 50 SMA which has rolled over from ~$297 to ~$282, confirming the medium-term downtrend, while the 200 SMA remains rising at $235.96 and price is still ~8% above it, maintaining the structural bull thesis. The 50/200 SMA relationship is bearish-leaning but the long-term trend is intact until the 200 SMA gives way; this is a healthy correction within a structural bull market, not the start of a multi-month bear cycle.
Market Cap
$232.7B
Share Price (52W High)
$334.03
Share Price (52W Low)
$152.73
50-Day MA
$283.07
200-Day MA
$237.93
Beta
1.325
P/E (TTM)
38.7x
Forward P/E
23.9x
PEG Ratio
0.9
P/B
12.9x
Dividend Yield
2.24%
Forward EPS
$10.64
TTM EPS
$6.59
Expected EPS Growth
+61%
Q2 2026 Revenue
$5,463M
Q2 2026 EPS
$2.14
Q2 2026 Net Income
$1,969M
TTM Revenue
$19.45B
Gross Margin (TTM)
~58.3%
Operating Margin (TTM)
42.6%
EBITDA Margin (TTM)
~48.9%
Net Margin (TTM)
31.1%
ROE (TTM)
35.2%
ROA (TTM)
13.1%
Current Ratio
4.86
Cash & Equivalents
$3,660M
Short-Term Investments
$3,341M
Total Cash & ST Investments
$7,001M
Total Assets
$35,882M
Total Debt
$14,052M
Net Debt
$10,392M
Stockholders' Equity
$18,007M
Goodwill & Intangibles
$4,644M
Net PP&E
$11,911M
Working Capital
$12.5B
Debt/Equity
78%
TTM FCF
$3.55B
Q2 2026 FCF
$2.19B
Q2 2026 OCF
$2,703M
Q2 2026 CapEx
$514M
Annual CapEx 2023
$5.07B
Annual CapEx 2025
$4.55B
Annual OCF 2022
$8.72B
Annual FCF 2022
$5.92B
Annual FCF 2023
$1.35B
Annual FCF 2025
$2.60B
Dividends Paid 2025
$5.00B
Buybacks 2025
$1.48B
TTM Buybacks
~$709M
Inventory
~$4.6B
Revenue 2024
$15.64B
Revenue 2025
$17.68B
Net Income 2024
$4.80B
Net Income 2025
$5.00B
Strengths
Concerns
TXN is in the early innings of a classic analog-semi up-cycle with Q2 2026 marking a clear inflection point—revenue jumped to a fresh cycle high of $5.46B (+22.8% YoY) and EPS expanded to $2.14 (+52% YoY) as operating leverage kicked in with 930 bps of margin expansion from the Q4 2025 trough. The marquee catalyst is the dramatic FCF inflection: quarterly CapEx has collapsed from ~$1.3B to $514M (down 61%) as the 300mm fab build-out matures, enabling Q2 2026 FCF of $2.19B—nearly 4x the year-ago quarter. The balance sheet remains fortress-like with $7.0B in cash and a current ratio of 4.86, while the company continues deleveraging with long-term debt declining from $14.04B to $12.90B year-over-year. The primary risk is that the stock has already moved substantially (+119% from 52W low), leaving TTM P/E at a rich 38.7x; the forward P/E of 23.9x and PEG of 0.9 provide reasonable room for error only if the cyclical recovery delivers as expected, and buyback resumption remains the likely next catalyst for incremental shareholder returns.
Macro: Hawkish Fed hold dominates with 89% no-cut 2026 pricing ($7.9M Polymarket volume, +1.6pp week-over-week) — rates expected to remain restrictive through year-end, a headwind for long-duration growth/AI names but a relative tailwind for cash-generative, dividend-paying cyclicals like TXN. Soft-landing narrative intact with only 8% US recession probability (down 1pp on the week); Japan and UK recession odds also small (6-8%). Inflation backdrop is mixed with UK CPI distribution biased toward the higher 3.5-3.9% bucket (27%), consistent with 'reflation-but-not-cutting.' Yields have stabilized off recent highs into early September — supportive for risk assets — but remain elevated and a live risk for multiple compression if oil-driven inflation fears resurface.